| Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients EP Krenning, DJ Kwekkeboom, WH Bakker, WAP Breeman, PPM Kooij, ... European journal of nuclear medicine 20, 716-731, 1993 | 1998 | 1993 |
| Peptide receptors as molecular targets for cancer diagnosis and therapy JC Reubi Endocrine reviews 24 (4), 389-427, 2003 | 1465 | 2003 |
| Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use JC Reubi, JC Schär, B Waser, S Wenger, A Heppeler, JS Schmitt, ... European journal of nuclear medicine 27, 273-282, 2000 | 1296 | 2000 |
| The role of somatostatin and its analogs in the diagnosis and treatment of tumors SWJ Lamberts, EP Krenning, JC Reubi Endocrine Reviews 12 (4), 450-482, 1991 | 1033 | 1991 |
| Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin EP Krenning, WAP Breeman, PPM Kooij, JS Lameris, WH Bakker, ... The Lancet 333 (8632), 242-244, 1989 | 885 | 1989 |
| Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands J Reubi, B Waser, JC Schaer, JA Laissue European journal of nuclear medicine 28 (7), 836-846, 2001 | 822 | 2001 |
| Somatostatin-receptor imaging in the localization of endocrine tumors SWJ Lamberts, WH Barker, JC Reubi, EP Krenning New England Journal of Medicine 323 (18), 1246-1249, 1990 | 704 | 1990 |
| Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting JC Reubi, B Waser European journal of nuclear medicine and molecular imaging 30, 781-793, 2003 | 696 | 2003 |
| The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei AJ Harmar, HM Marston, S Shen, C Spratt, KM West, WJ Sheward, ... Cell 109 (4), 497-508, 2002 | 655 | 2002 |
| Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation R Markwalder, JC Reubi Cancer research 59 (5), 1152-1159, 1999 | 639 | 1999 |
| Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours U Plöckinger, G Rindi, R Arnold, B Eriksson, EP Krenning, WW De Herder, ... Neuroendocrinology 80 (6), 394-424, 2004 | 630 | 2004 |
| Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide EP Krenning, WH Bakker, PPM Kooij, WAP Breeman, HY Oei, M De Jong, ... Journal of Nuclear Medicine 33 (5), 652-658, 1992 | 608 | 1992 |
| Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors M Ginj, H Zhang, B Waser, R Cescato, D Wild, X Wang, J Erchegyi, ... Proceedings of the National Academy of Sciences 103 (44), 16436-16441, 2006 | 576 | 2006 |
| GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting M Körner, M Stöckli, B Waser, JC Reubi Journal of Nuclear Medicine 48 (5), 736-743, 2007 | 498 | 2007 |
| Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors JC Reubi, JC Schaer, B Waser Cancer research 57 (7), 1377-1386, 1997 | 470 | 1997 |
| Bombesin Receptor Subtypes in Human Cancers: Detection with the Universal Radioligand 125I-[d-TYR6, β-ALA11, PHE13, NLE14] Bombesin(6–14) JC Reubi, S Wenger, J Schmuckli-Maurer, JC Schaer, M Gugger Clinical Cancer Research 8 (4), 1139-1146, 2002 | 464 | 2002 |
| Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? P Antunes, M Ginj, H Zhang, B Waser, RP Baum, JC Reubi, H Maecke European journal of nuclear medicine and molecular imaging 34, 982-993, 2007 | 455 | 2007 |
| Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas JC Reubi, LK Kvols, B Waser, DM Nagorney, PU Heitz, JW Charboneau, ... Cancer research 50 (18), 5969-5977, 1990 | 449 | 1990 |
| DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals D Wild, JS Schmitt, M Ginj, HR Mäcke, BF Bernard, E Krenning, ... European journal of nuclear medicine and molecular imaging 30, 1338-1347, 2003 | 382 | 2003 |
| Expression and Localization of Somatostatin Receptor SSTR1, SSTR2, and SSTR3 Messenger RNAs in Primary Human Tumors using in Situ Hybridization JC Reubi, JC Schaer, B Waser, G Mengod Cancer Research 54 (13), 3455-3459, 1994 | 379 | 1994 |
